Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02057770 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Low accrual rate

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: busulfan
DRUG: fludarabine phosphate
RADIATION: total-body irradiation (TBI)
PROCEDURE: Stem cell transplant
DRUG: cyclophosphamide
DRUG: tocilizumab

Sponsor

Washington University School of Medicine